Economic Evaluation in Clinical Trials

Henry A. Glick, Jalpa A. Doshi, Seema S. Sonnad and Daniel Polsky
Additional contact information
Henry A. Glick: Professor of Medicine, Division of General Internal Medicine, Perelman School of Medicine; Professor of Health Care Systems, Wharton School; Senior Fellow, Leonard Davis Institute of Health Economics; Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, USA; Visiting Professor, Institute of Health and Wellbeing, University of Glasgow, United Kingdom
Jalpa A. Doshi: Associate Professor of Medicine, Division of General Internal Medicine, Perelman School of Medicine; Director, Economic Evaluations Unit, Center for Evidence-Based Practice; Director, Value-Based Insurance Design Initiatives; Center for Health Incentives and Behavioural Economics; Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, USA
Seema S. Sonnad: Director of Health Services Research, The Value Institute, Christiana Care Health System, USA; Adjunct Associate Professor, Department of Surgery, Perelam School of Medicine, Adjunct Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania, USA
Daniel Polsky: Robert D. Eilers Professor, Health Care Management, The Wharton School; Professor of Medicine, Division of General Internal Medicine, Perelam School of Medicine; Executive Director, Leonard Davis Institute of Health Economics; University of Pennsylvania, USA

in OUP Catalogue from Oxford University Press

Abstract: It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, drugs, devices or diagnostics. It can aid companies seeking to make claims about the cost-effectiveness of their product, as well as allowing early consideration of the economic value of therapies which may be important to improving initial adoption decisions. It is also vital for addressing the requirements of regulatory bodies. Economic Evaluation in Clinical Trials provides practical advice on how to conduct cost-effectiveness analyses in controlled trials of medical therapies. This new edition has been extensively rewritten and revised; topics discussed range from design issues such as the types of services that should be measured and price weights, to assessment of quality-adjusted life years. Illustrative materials, case histories and worked examples are included to encourage the reader to apply the methods discussed. These exercises are supported with datasets, programmes and solutions made available online.

Date: 2014
Edition: 2
ISBN: 9780199685028
References: Add references at CitEc
Citations: View citations in EconPapers (30)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oxp:obooks:9780199685028

Ordering information: This item can be ordered from
http://ukcatalogue.o ... uct/9780199685028.do

Access Statistics for this book

More books in OUP Catalogue from Oxford University Press
Bibliographic data for series maintained by Economics Book Marketing ().